알부민(부형제) 시장 규모, 점유율 및 성장 분석 : 제품 유형·등급별, 조달원별, 기능적 응용 계층별, 최종사용자 시설별, 지역별 - 업계 예측(2026-2033년)

Global Albumin As Excipient Market size was valued at USD 228.28 Million in 2024 and is poised to grow from USD 233.32 Million in 2025 to USD 277.91 Million by 2033, growing at a CAGR of 2.21% during the forecast period (2026-2033).

The global market for albumin as an excipient is experiencing significant growth due to its natural properties as a stabilizer for pharmaceuticals, vaccines, and diagnostic kits. Albumin's biocompatibility and binding capacity are crucial for preserving fragile active ingredients during storage and transport. The rise of biologics and mRNA vaccines has particularly driven this expansion, exemplified by albumin's role in enhancing lipid-nanoparticle stability. The burgeoning application of albumin in therapies is reshaping demand, as it reduces immunogenic risk and improves drug solubility. Furthermore, advancements in AI-driven automation are streamlining manufacturing processes, enhancing quality control, and reducing costs, thereby making albumin an increasingly attractive option. As healthcare spending rises, suppliers are focused on recombinant albumin production to meet the growing need for pathogen-free sources, positioning themselves for future growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Albumin As Excipient market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Albumin As Excipient Market Segments Analysis

Global albumin as excipient market is segmented by product type grade, sourcing origin, functional application layer, end-user facility and region. Based on product type grade, the market is segmented into Human Serum Albumin, Recombinant Albumin and Bovine Serum Albumin. Based on sourcing origin, the market is segmented into Plasma-Derived Sourcing and Recombinant Expression Systems. Based on functional application layer, the market is segmented into Injectable Drug Formulations, Vaccine Stabilization Formulations, Cell Culture and Bioprocessing Media, Diagnostic Reagent Formulations and Therapeutics and Medical Supplements. Based on end-user facility, the market is segmented into Pharmaceutical and Biotechnology Companies, Contract Development and Manufacturing Organizations, Research Institutes and CROs and Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Albumin As Excipient Market

The global demand for albumin as an excipient is being driven by pharmaceutical manufacturers who recognize its exceptional benefits in biologic formulations. Albumin offers enhanced protein stabilization, minimizes aggregation, and prolongs shelf life, all of which are crucial for the advancement of high-potency therapies and complex manufacturing processes. This has led to an increased investment from suppliers in scaling production capabilities and enhancing quality assurance. Additionally, the rising inclination towards biologics across various therapeutic areas further propels this trend, ensuring compliance with regulatory standards across different regions and fostering a robust market for albumin as an excipient.

Restraints in the Global Albumin As Excipient Market

The Global Albumin as Excipient market faces notable constraints primarily due to the complex extraction and purification processes that demand substantial capital investment and specialized operational expertise. This results in elevated production costs, leading to higher prices for the excipient, which can be a significant barrier for generic drug manufacturers and smaller biopharmaceutical companies. Consequently, many firms may turn to alternative, more cost-effective excipients, hindering overall market growth. Additionally, the sensitivity of formulation budgets to costs exacerbates this challenge, restricting the broader use of albumin despite its valuable functional advantages in critical care formulations and vaccine development.

Market Trends of the Global Albumin As Excipient Market

The Global Albumin As Excipient market is witnessing a significant trend towards eco-friendly formulations, as pharmaceutical manufacturers increasingly focus on sustainability in their product lines. This shift is driven by a commitment to lower carbon footprints and meet the growing demand for environmentally responsible excipients, prompting a preference for albumin sourced from sustainable feedstocks and produced with minimal solvent usage. Companies that can demonstrate eco-friendly sourcing and provide transparent lifecycle assessments gain a competitive edge, encouraging suppliers to enhance their manufacturing practices. This landscape fosters strategic partnerships and continuous innovation, as stakeholders across the industry prioritize sustainability-driven initiatives globally.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Albumin as Excipient Market Size by Product Type Grade & CAGR (2026-2033)

• Market Overview
• Human Serum Albumin
• Recombinant Albumin
• Bovine Serum Albumin

Global Albumin as Excipient Market Size by Sourcing Origin & CAGR (2026-2033)

• Market Overview
• Plasma-Derived Sourcing
• Recombinant Expression Systems
  • Yeast Expression Platforms
  • Rice Expression Platforms
  • Transgenic Plant Platforms

Global Albumin as Excipient Market Size by Functional Application Layer & CAGR (2026-2033)

• Market Overview
• Injectable Drug Formulations
• Vaccine Stabilization Formulations
• Cell Culture and Bioprocessing Media
• Diagnostic Reagent Formulations
• Therapeutics and Medical Supplements

Global Albumin as Excipient Market Size by End-User Facility & CAGR (2026-2033)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Contract Development and Manufacturing Organizations
• Research Institutes and CROs
• Hospitals and Clinics

Global Albumin as Excipient Market Size & CAGR (2026-2033)

• North America (Product Type Grade, Sourcing Origin, Functional Application Layer, End-User Facility)
  • US
  • Canada
• Europe (Product Type Grade, Sourcing Origin, Functional Application Layer, End-User Facility)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type Grade, Sourcing Origin, Functional Application Layer, End-User Facility)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type Grade, Sourcing Origin, Functional Application Layer, End-User Facility)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type Grade, Sourcing Origin, Functional Application Layer, End-User Facility)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Grifols S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Behring LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Octapharma AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotest AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kedrion Biopharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LFB USA Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novonesis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InVitria Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Albumin Therapeutics LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Products Laboratory Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ventria Bioscience Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• China Biologic Products Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiMedia Laboratories Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RayBiotech Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SeraCare Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medxbio Pte Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Elements
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations